Obstructive Coronary Artery Disease
6
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Comprehensive Invasive Physiological Evaluation of Obstructive Coronary Artery Disease
µQFR for Branch Stenosis After Single Stent in Bifurcation Lesions
Coronary Revascularization Versus Conservative Therapy in Patients With Treated Critical Limb Ischemia
Gadofosveset Trisodium for Heart Imaging Studies
YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering
Catheter-Based Treatment of Cardiovascular Disease